Ovid Therapeutics Inc (OVID) — Long-term Investment Intensity
Ovid Therapeutics Inc (OVID) has a Long-term Investment Intensity of 41.6% as of December 2025. Long-term investments of $62.77 Million represent 41.6% of total assets of $150.93 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Ovid Therapeutics Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Ovid Therapeutics Inc Long-term Investment Intensity (2021–2025)
This chart shows how Ovid Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 41.6%, reflecting long-term investments of $62.77 Million against total assets of $150.93 Million USD. Also explore Ovid Therapeutics Inc total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Ovid Therapeutics Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Ovid Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see OVID stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 41.6% | $62.77 Million | $150.93 Million | ▲ +18.8 pp |
| 2024 | 22.8% | $20.97 Million | $92.17 Million | ▲ +10.5 pp |
| 2023 | 12.2% | $17.63 Million | $144.03 Million | ▲ +8.6 pp |
| 2022 | 3.6% | $5.62 Million | $155.27 Million | ▲ +2.8 pp |
| 2021 | 0.8% | $1.63 Million | $194.54 Million | — |